Abstract
BACKGROUND Inclisiran (ALN-PCSsc) is a long-acting RNA interference (RNAi) therapeutic agent that inhibits the synthesis of proprotein convertase subt......
小提示:本篇文献需要登录阅读全文,点击跳转登录